FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/02/012106 [Registered on: 23/02/2018] Trial Registered Prospectively
Last Modified On: 12/02/2018
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Knowledge, Attitude and the Practice of Pharmacovigilance among the healthcare professionals  
Scientific Title of Study   Knowledge, Attitude, and the Practice (KAP) of Pharmacovigilance among the healthcare professionals in a tertiary care hospital in Rajasthan, India 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Surjit Singh 
Designation  Associate Professor 
Affiliation  All India Institute of Medical Sciences Jodhpur 
Address  Deaprtment of Pharmacology AIIMS Jodhpur Rajasthan

Jodhpur
RAJASTHAN
342005
India 
Phone  8003996895  
Fax    
Email  sehmby_ss@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Surjit Singh 
Designation  Associate Professor 
Affiliation  All India Institute of Medical Sciences Jodhpur 
Address  Deaprtment of Pharmacology AIIMS Jodhpur Rajasthan


RAJASTHAN
342005
India 
Phone  8003996895  
Fax    
Email  sehmby_ss@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Surjit Singh 
Designation  Associate Professor 
Affiliation  All India Institute of Medical Sciences Jodhpur 
Address  Deaprtment of Pharmacology AIIMS Jodhpur Rajasthan


RAJASTHAN
342005
India 
Phone  8003996895  
Fax    
Email  sehmby_ss@yahoo.com  
 
Source of Monetary or Material Support  
All India Institute of Medical Sciences Jodhpur Basni -2, AIIMS Jodhpur Rajasthan - 342005 
 
Primary Sponsor  
Name  All India Institute of Medical Sciences Jodhpur 
Address  Basni Industrial Area -2 AIIMS Jodhpur Rajasthan 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Surjit Singh  All India Institute of Medical Sciences Jodhpur  C- 291, Department of Pharmacology AIIMS Jodhpur Rajasthan - 342005
Jodhpur
RAJASTHAN 
8003996895

sehmby_ss@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Healthy Human Volunteers 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  None  None 
Comparator Agent  None  None 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Doctors working in Clinical and Nonclinical departments of AIIMS, Jodhpur
2. Doctors willing to give written informed consent.
 
 
ExclusionCriteria 
Details  None 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evaluate the knowledge, attitude, and practices (KAP) of the healthcare professionals about pharmacovigilance in All India institute of medical Sciences, Jodhpur (Rajasthan), a tertiary care teaching hospital.  Single point recording at the time of enrolment 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the causation of underreporting of adverse drug reactions (ADRs) as it needs to be well-assessed in India.  Single time point recording at the time of enrolment 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/03/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Methodology

A cross-sectional study will be carried out using a pretested questionnaire. The questionnaire will be designed to assess the KAP regarding pharmacovigilance. The healthcare professionals (doctors, nurses, and pharmacists) working in the AIIMS, Jodhpur (Rajasthan) during the study period will be included. Only those who gave their consent to participate were included in the study. Face Validity of the questionnaire has been confirmed by sending it to 10 experts in the field of medicine and modifying the questionnaire as per their suggestions and comments. Care will be taken to protect the confidentiality and anonymity of participants. Data analysis was done using Statistical Package for Social Sciences (SPSS) version 21.

Inclusion Criteria:

1.      Doctors working in Clinical and Nonclinical departments of AIIMS, Jodhpur

2.      Doctors willing to give written informed consent.

Exclusion Criteria: None

Design: Cross sectional study and survey.

Study group: Clinical, Non Clinical and Para Clinical Doctors in Tertiary care hospital.

Evaluation: Responses of the doctors will be recorded and analysed. Confidentiality and anonymity of the participants will be maintained as no personal information will be recorded on the questionnaire. After the responses are recoded, comparison will be done with regard to knowledge, attitude and practice of pharmacovigilance among consultant and residents and also among doctors of clinical and non-clinical doctors.

Statistical Analysis

Information from the returned pretested questionnaire will be coded and entered into Statistical Package for Social Sciences (SPSS) software version 21. Spearman’s correlation will be used to determine any relationship between training of pharmacovigilance and reporting ADR.

 
Close